TCM
MEDP icon

Tygh Capital Management’s Medpace MEDP Stock Holding History

Tygh Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-69,560
Closed -$2.08M – 100
2016
Q3 		$2.08M Buy
+69,560
New +$2.03M 0.56% 74

Other funds holding MEDP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
FA
Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Tygh Capital Management's MEDP Position: Q4 2016 in Review

Tygh Capital Management sold out of Medpace (MEDP) in Q4 2016, closing a stake of 69,560 shares — an estimated $2.08M sold.

Tygh Capital Management first reported a position in MEDP in Q3 2016 and held it in 1 quarter. The position peaked at $2.08M in Q3 2016. 79 funds tracked by Wall St. Rank hold MEDP as of Q4 2016.

  • Tygh Capital Management reported no remaining Medpace position as of Q4 2016 after selling out during the quarter.
  • Tygh Capital Management sold 69,560 Medpace shares in Q4 2016, an estimated $2.08M.
  • Tygh Capital Management first reported a position in Medpace in Q3 2016 and held it in 1 quarter.
  • Tygh Capital Management's Medpace position peaked at $2.08M in Q3 2016.
  • 79 funds tracked by Wall St. Rank held Medpace as of Q4 2016.

Based on Tygh Capital Management's 13F filing for Q4 2016, filed 31 Jan 2017.